Helix Biotech

Exhibitor

Helix Biotech is an innovative Contract Development and Manufacturing Organization (CDMO) specializing in the design, development, and production of Lipid Nanoparticles (LNPs), Liposomes, and Hybrid Nanoparticles. With a steadfast commitment to innovation, quality, and customer collaboration, we empower researchers and pharmaceutical companies to advance their pre-clinical and clinical stage projects. Our portfolio includes nanoparticle manufacturing systems, reagent kits, and off-the-shelf mRNA designed to streamline development, manufacturing, and analytical processes. At Helix Biotech, we are more than a service provider—we are your trusted partner in delivering your transformative therapies to the world.

  • Custom mRNA synthesis services: Tailored sequence design, scalable production, and rigorous quality control to meet diverse research and therapeutic needs
  • Formulation, Development, and Screening: Specializing in nanoparticles (10–500 nm) such as lipid nanoparticles, liposomes, emulsions, and polymer-based particles at various scales from proof-of-concept to large-scale GMP production.
  • GMP Process Development: Collaborative process development with knowledge transfer to client staff, ensuring clients fully own the developed processes.
  • GMP Analytical Method Development: Offering compendial and customized analytical methods, including method transfer, feasibility, verification, qualification, and validation.
  • Contract Manufacturing: Providing dedicated clean and sterile processing facilities, batch production, lot release, aseptic fill/finish, technology transfer, and compliance with 21 CFR Part 210/211 and ICH guidelines.


website